Detalhe da pesquisa
1.
Discovery of LYC-55716: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ) Agonist for Use in Treating Cancer.
J Med Chem
; 64(18): 13410-13428, 2021 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34499493
2.
Exploration of 4,4-disubstituted pyrrolidine-1,2-dicarboxamides as potent, orally active Factor Xa inhibitors with extended duration of action.
Bioorg Med Chem
; 17(6): 2501-11, 2009 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19231206
3.
Binding thermodynamics of substituted diaminopyrimidine renin inhibitors.
Anal Biochem
; 360(1): 30-40, 2007 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17113558
4.
Rational design of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as small molecule renin inhibitors.
Bioorg Med Chem
; 15(17): 5912-49, 2007 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17574423
5.
Structure-based drug design of pyrrolidine-1, 2-dicarboxamides as a novel series of orally bioavailable factor Xa inhibitors.
Chem Biol Drug Des
; 69(6): 444-50, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17581239
6.
The discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an orally efficacious factor Xa inhibitor.
Chem Biol Drug Des
; 70(2): 100-12, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17683371
7.
The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex--Part 2.
Bioorg Med Chem Lett
; 16(4): 1060-4, 2006 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16289811
8.
The discovery of fluoropyridine-based inhibitors of the Factor VIIa/TF complex.
Bioorg Med Chem Lett
; 15(21): 4752-6, 2005 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16125385